Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: ALCHEM LABORATORIES CORPORATION
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2020-04-14 to 2024-08-05
Current total value of award: $4668079
Description: A MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, MULTI-ARM HISTORICAL CONTROL, COMPARATIVE TRIAL OF THE SAFETY AND EFFICACY OF HYDROXYCHLOROQUINE AND THE COMBINATION OF HYDROXYCHLOROQUINE AND FAMOTIDINE FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 DISEASE